Table 2.
CMR results
| Parameter | Entire group | Suspected CAD | Known CAD | p |
|---|---|---|---|---|
| (n = 159) | (n = 72) | (n = 87) | ||
| LV-EF (%) | 54 [39–66] | 61 [45–67] | 50 [34–64] | 0.04 |
| LV-EDV (ml) | 124 [101–168] | 116 [91–145] | 133 [106–181] | 0.01 |
| LV-ESV (ml) | 54 [32–98] | 49 [28–69] | 68 [40–109] | 0.007 |
| LA (cm2) | 26 [21–35] | 27 [22–38] | 26 [21–34] | 0.43 |
| IVS (mm) | 12 [10–13] | 11 [10–13] | 12 [10–14] | 0.58 |
| Ischemia LCA | 49 (31 %) | 13 (18 %) | 36 (41 %) | 0.001 |
| Ischemia RCA | 36 (23 %) | 7 (10 %) | 29 (33 %) | <0.001 |
| CAD-type LGE | 74 (47 %) | 15 (21 %) | 59 (68 %) | <0.001 |
Values are median [IQR], or n (%)
CAD coronary artery disease, suspected CAD CMR work-up of suspected CAD in patients without history of CAD, known CAD CMR work-up of ischemia in patients with prior myocardial infarction and/or revascularization procedure (PCI or CABG), LV left ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, LA left atrium, IVS interventricular septum, LCA LM + LAD + LCX, LCA left coronary artery, LM left main, LAD left anterior descending, LCX left circumflex artery, LGE late gadolinium enhancement